DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▼ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0019196 | Hepatitis C | GP2 | 2813 | glycoprotein 2 | P55259 |
C0009324 | Ulcerative Colitis | GP2 | 2813 | glycoprotein 2 | P55259 |
C0017178 | Gastrointestinal Diseases | GP2 | 2813 | glycoprotein 2 | P55259 |
C0021390 | Inflammatory Bowel Diseases | GP2 | 2813 | glycoprotein 2 | P55259 |
C1832661 | ANOPHTHALMIA AND PULMONARY HYPOPLASIA | GP2 | 2813 | glycoprotein 2 | P55259 |
C0346647 | Malignant neoplasm of pancreas | GP2 | 2813 | glycoprotein 2 | P55259 |
C0282687 | Hemorrhagic Fever, Ebola | GP2 | 2813 | glycoprotein 2 | P55259 |
C0268151 | Classical galactosemia | GP2 | 2813 | glycoprotein 2 | P55259 |
C0016977 | Gall Bladder Diseases | GP2 | 2813 | glycoprotein 2 | P55259 |
C0023467 | Leukemia, Myelocytic, Acute | GP2 | 2813 | glycoprotein 2 | P55259 |
C0019360 | Herpes zoster disease | GP2 | 2813 | glycoprotein 2 | P55259 |
C0242379 | Malignant neoplasm of lung | AMY2B | 280 | amylase alpha 2B | P19961 |
C0020758 | Congenital ichthyosis | AMY2B | 280 | amylase alpha 2B | P19961 |
C0020757 | Ichthyoses | AMY2B | 280 | amylase alpha 2B | P19961 |
C0027051 | Myocardial Infarction | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0018889 | Helminthiasis | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0020445 | Hypercholesterolemia, Familial | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0006826 | Malignant Neoplasms | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0007138 | Carcinoma, Transitional Cell | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0677886 | Epithelial ovarian cancer | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0007097 | Carcinoma | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0346647 | Malignant neoplasm of pancreas | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0010068 | Coronary heart disease | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C1306459 | Primary malignant neoplasm | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0152018 | Esophageal carcinoma | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024